BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37390813)

  • 1. Traits of Patients With Pituitary Tumors in Multiple Endocrine Neoplasia Type 1 and Comparing Different Mutation Status.
    Lin KY; Kuo YT; Cheng MF; Chen PL; Wang HP; Cheng TY; Chang CH; Kao HF; Yang SH; Li HY; Lin CH; Chou YT; Chung AK; Wu WC; Lu JY; Wang CY; Hsih WH; Wen CY; Yang WS; Shih SR
    J Clin Endocrinol Metab; 2023 Nov; 108(12):e1532-e1541. PubMed ID: 37390813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG).
    de Laat JM; Dekkers OM; Pieterman CR; Kluijfhout WP; Hermus AR; Pereira AM; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; de Herder WW; Valk GD
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3288-96. PubMed ID: 26126205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience.
    Cohen-Cohen S; Brown DA; Himes BT; Wheeler LP; Ruff MW; Major BT; Singh Ospina NM; Atkinson JLD; Meyer FB; Bancos I; Young WF; Van Gompel JJ
    J Neurosurg; 2020 Apr; 134(3):1132-1138. PubMed ID: 32244213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China.
    Wu Y; Gao L; Guo X; Wang Z; Lian W; Deng K; Lu L; Xing B; Zhu H
    Pituitary; 2019 Apr; 22(2):113-123. PubMed ID: 30637623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary tumors in patients with MEN1 syndrome.
    Syro LV; Scheithauer BW; Kovacs K; Toledo RA; Londoño FJ; Ortiz LD; Rotondo F; Horvath E; Uribe H
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):43-8. PubMed ID: 22584705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
    Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique gene expression profile associated with an early-onset multiple endocrine neoplasia (MEN1)-associated pituitary adenoma.
    Farrell WE; Azevedo MF; Batista DL; Smith A; Bourdeau I; Horvath A; Boguszewski M; Quezado M; Stratakis CA
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1905-14. PubMed ID: 21917868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
    Gaztambide S; Vazquez F; Castaño L
    Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEN1 and pituitary adenomas.
    Delemer B
    Ann Endocrinol (Paris); 2012 Apr; 73(2):59-61. PubMed ID: 22542456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in MEN1 gene study for pituitary tumor pathogenesis.
    Kameya T; Tsukada T; Yamaguchi K
    Front Horm Res; 2004; 32():265-91. PubMed ID: 15281352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
    Vergès B; Boureille F; Goudet P; Murat A; Beckers A; Sassolas G; Cougard P; Chambe B; Montvernay C; Calender A
    J Clin Endocrinol Metab; 2002 Feb; 87(2):457-65. PubMed ID: 11836268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.
    Stratakis CA; Schussheim DH; Freedman SM; Keil MF; Pack SD; Agarwal SK; Skarulis MC; Weil RJ; Lubensky IA; Zhuang Z; Oldfield EH; Marx SJ
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4776-80. PubMed ID: 11134142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
    Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
    Marini F; Giusti F; Brandi ML
    Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.
    Newey PJ; Jeyabalan J; Walls GV; Christie PT; Gleeson FV; Gould S; Johnson PR; Phillips RR; Ryan FJ; Shine B; Bowl MR; Thakker RV
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3640-6. PubMed ID: 19622622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular features of four Brazilian families with multiple endocrine neoplasia type 1.
    Miranda ISM; Valadares LP; Barra GB; Mesquita PG; de Santana LB; de Castro LF; Rita THS; Naves LA
    Front Endocrinol (Lausanne); 2023; 14():1117873. PubMed ID: 36967793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.
    Sakurai A; Katai M; Yumita W; Minemura K; Hashizume K
    Endocrine; 2004 Feb; 23(1):45-9. PubMed ID: 15034196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapies for patients with multiple endocrine neoplasia type 1.
    Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
    Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors.
    Evans CO; Brown MR; Parks JS; Oyesiku NM
    J Endocrinol Invest; 2000 May; 23(5):304-9. PubMed ID: 10882148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.